![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/22 | |
A61K 31/713 | |||
A61K 31/7088 | |||
A61K 31/59 | |||
A61K 38/17 | |||
A61K 38/18 | |||
A61K 39/395 | |||
A61K 45/06 | |||
A61L 27/12 | |||
A61L 27/54 |
(11) | Number of the document | 2144613 |
(13) | Kind of document | T |
(96) | European patent application number | 07875255.7 |
Date of filing the European patent application | 2007-12-21 | |
(97) | Date of publication of the European application | 2010-01-20 |
(45) | Date of publication and mention of the grant of the patent | 2018-03-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/088542 |
Date | 2007-12-21 |
(87) | Number | WO 2009/131553 |
Date | 2009-10-29 |
(30) | Number | Date | Country code |
882642 P | 2006-12-29 | US |
(72) |
ELLIES, Debra, L., US
|
(73) |
Ossifi-Mab LLC ,
11235 Mastin Street, Suite 102
Overland Park, Kansas 66210,
US
|
(54) | METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST |
METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST |